NIVF
NewGenIvfNIVF
NIVF
About: NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.
Employees: 70
0
Funds holding %
of 7,139 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
0.15% more ownership
Funds ownership: 1.36% [Q3] → 1.52% (+0.15%) [Q4]
0% more funds holding
Funds holding: 7 [Q3] → 7 (+0) [Q4]
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
35% less capital invested
Capital invested by funds: $94.3K [Q3] → $61.3K (-$32.9K) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for NIVF.
Financial journalist opinion
Based on 3 articles about NIVF published over the past 30 days
Neutral
GlobeNewsWire
1 day ago
NewGen Issues Clarification on Press Release Titled “NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director” dated February 20, 2025
BANGKOK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”) today issued a clarification that, in the press release titled “NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director” issued on February 20, 2025, the Company did not intend to imply that it has already achieved compliance with the Nasdaq Capital Market's $2.5 million minimum stockholders' equity requirement (the “Equity Rule”). However, during its 1st quarter to date, certain NewGen debtholders converted $2.3 million of debt to equity and the Company has drawn down approximately $4.3 million from its Equity Line of Credit with White Lion Capital. Therefore, the Company believes it has in excess of $2.5 million in stockholders' equity as of this date. The Company is awaiting confirmation from Nasdaq that it has evidenced compliance with the Equity Rule. However, there can be no assurance that Nasdaq will determine that the Company has regained compliance with the Nasdaq continued listing rules.
Neutral
GlobeNewsWire
2 days ago
NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director
Company Granted Request to Continue its Listing on Nasdaq Appoints Thorain Ko to Lead Business Development Initiatives
Neutral
GlobeNewsWire
3 weeks ago
NewGen Announces Reverse Stock Split
NewGen's ordinary shares to begin trading on a split-adjusted basis on February 11, 2025 NewGen's ordinary shares to begin trading on a split-adjusted basis on February 11, 2025
Neutral
GlobeNewsWire
1 month ago
NewGen Announces Strategic Acquisition of MicroSort Reproductive Technology
The technology, which will be acquired for US$5 million, allows for t he separation of X and Y chromosome-bearing sperm cells
Neutral
GlobeNewsWire
1 month ago
NewGen Launches Innovative Lifetime Egg Freezing Service to Address Growing Market Need in Asia
New service will address a significant market opportunity and grant new flexibility to women seeking reproductive flexibility New service will address a significant market opportunity and grant new flexibility to women seeking reproductive flexibility
Neutral
GlobeNewsWire
2 months ago
NewGen Progresses Reverse Merger Plans with Engagement of Legal Teams and Updated Timeline
BANGKOK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”) today announced that both parties involved in the previously announced reverse merger with European Wellness Investment Holdings Limited (“EWIHL”) have appointed legal counsel to prepare the Share Purchase Agreement (the “SPA”). Additionally, by mutual consent, the signing date for the SPA has been extended from January 27, 2025, to February 28, 2025. This extension will allow both parties sufficient time to complete the necessary due diligence, finalize the terms of the agreement, and ensure compliance with all relevant NASDAQ requirements for reverse mergers.
Neutral
GlobeNewsWire
3 months ago
NewGenIvf Receives Nasdaq Delisting Notice and Plans to Submit Appeal, Announces Strategic Path Forward to Regain Compliance
Multiple strategic initiatives include applying to transfer to Nasdaq Capital Market, leveraging recent fundraising arrangements to boost equity Multiple strategic initiatives include applying to transfer to Nasdaq Capital Market, leveraging recent fundraising arrangements to boost equity
Neutral
GlobeNewsWire
4 months ago
NewGenIvf Receives Nasdaq Notification Regarding Minimum Bid Price
BANGKOK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), today announced that on October 8, 2024, the Company received a letter (the “Deficiency Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is currently not in compliance with the closing bid price requirement under Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Rule”).
Neutral
GlobeNewsWire
6 months ago
NewGenIvf Announces Filing of 2023 Annual Report with the SEC
Total Revenues Reach US$5.1 Million Gross Profit Increases by 9.4% to US$1.7 Million Net Income of US$0.1 million
Neutral
GlobeNewsWire
7 months ago
NewGenIvf Provides Update on Potential Reverse Merger with COVIRIX
BANGKOK, July 24, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced an update on its proposed reverse merger (the “Proposed Transaction”) with pharmaceutical company COVIRIX Medical Pty Ltd ("COVIRIX"). The Company reports steady progress in its due diligence efforts and, contingent upon meeting all regulatory requirements, anticipates completing the Proposed Transaction by the end of August 2024.
Charts implemented using Lightweight Charts™